Gaps between Global Guidelines and Local Practices in CKD-MBD.
- Author:
Gheun Ho KIM
1
Author Information
- Publication Type:Review
- Keywords: Calcium; Hemodialysis; Mortality; Parathyroid hormone; Phosphorus
- MeSH: Calcium; Dialysis; Humans; Kidney; Kidney Diseases; Mortality; Parathyroid Hormone; Phosphorus; Renal Dialysis
- From:Electrolytes & Blood Pressure 2014;12(2):35-40
- CountryRepublic of Korea
- Language:English
- Abstract: The term 'chronic kidney disease-mineral bone disorder' (CKD-MBD) is a new term that, in contrast to the old term 'renal osteodystrophy', implies a systemic syndrome associated with cardiovascular morbidity and mortality. This new terminology is in line with previous studies that show elevated serum calcium, phosphorus, and parathyroid hormone (PTH) levels associated with increased cardiovascular and all-cause mortality. In order to improve outcomes in patients with CKD-MBD, many countries have developed clinical practice guidelines. Globally, the Kidney Disease Outcome Quality Initiative (KDOQI) and Kidney Disease: Improving Global Outcomes (KDIGO) guidelines are the most commonly used. However, whether these global guidelines can be successfully implemented on a local level needs to be studied. Differences in medical care and social factors between countries may limit the generalizability of global guidelines. Reports from the Korean registry and the Dialysis Outcomes and Practice Patterns Study (DOPPS) suggest that many dialysis patients are not within the target ranges recommended by the KDOQI and KDIGO guidelines for serum calcium, phosphorus, and PTH, suggesting gaps between global guidelines and local practices. Clinical studies with Korean CKD-MBD patients are necessary to compare Korean practices and outcomes to those suggested by global guidelines and to determine the target serum mineral levels associated with the best local outcomes.
